• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[克拉霉素在唾液中的渗透及其对正常唾液细菌菌群的影响]

[Penetration of clarithromycin to saliva and its effect on normal salivary bacterial flora].

作者信息

Morihana T, Kaneko A, Tomita F, Suwa T, Kohno Y, Kobayashi I

机构信息

Department of Oral Surgery, Ashikaga Red Cross Hospital.

出版信息

Jpn J Antibiot. 1989 Apr;42(4):973-82.

PMID:2528003
Abstract

Clarithromycin (TE-031, A-56268), a new macrolide antibiotic, was administered to rats, and the distribution of the drug in the submandibular gland was studied using microautoradiography. The study revealed good accumulation of 14C-TE-031 in both the acini and the excretory ducts. TE-031 was administered to each of 3 healthy male volunteers in a single dose of 300 mg, and its concentrations in the serum and saliva was detected. Mean values of various pharmacokinetic parameters were as follows for the serum and saliva, respectively. Cmax 1.49 micrograms/ml and 1.93 micrograms/ml; Tmax 2.91 hours and 2.66 hours; T 1/2 6.31 hours and 4.15 hours; AUC 18.58 micrograms.hr/ml and 17.70 micrograms.hr/ml. Regarding the salivary bacterial flora, the total bacterial count decreased as the salivary TE-031 concentration increased, but it recovered to the initial level in 12 hours after administration. During the 24-hour period following an administration of TE-031, the salivary bacteria did not acquire resistance to the drug. Therefore, TE-031 is an antibiotic which exerts little effect on the normal salivary bacterial flora in short-term administration. Although the results differed among the individuals, the penetration of TE-031 to saliva was superior to that to the serum. Thus, TDM of TE-031 using salivary samples is possible.

摘要

新型大环内酯类抗生素克拉霉素(TE - 031,A - 56268)被给予大鼠,并使用微量放射自显影术研究了该药物在颌下腺中的分布。研究显示14C - TE - 031在腺泡和排泄管中均有良好的蓄积。给3名健康男性志愿者每人单次服用300mg TE - 031,并检测其血清和唾液中的浓度。血清和唾液的各种药代动力学参数平均值分别如下。Cmax为1.49微克/毫升和1.93微克/毫升;Tmax为2.91小时和2.66小时;T 1/2为6.31小时和4.15小时;AUC为18.58微克·小时/毫升和17.70微克·小时/毫升。关于唾液细菌菌群,随着唾液中TE - 031浓度的增加,细菌总数减少,但给药后12小时恢复到初始水平。在给予TE - 031后的24小时内,唾液细菌未对该药物产生耐药性。因此,TE - 031是一种在短期给药时对正常唾液细菌菌群影响较小的抗生素。尽管个体之间结果存在差异,但TE - 031在唾液中的渗透优于在血清中的渗透。因此,使用唾液样本进行TE - 031的治疗药物监测是可行的。

相似文献

1
[Penetration of clarithromycin to saliva and its effect on normal salivary bacterial flora].[克拉霉素在唾液中的渗透及其对正常唾液细菌菌群的影响]
Jpn J Antibiot. 1989 Apr;42(4):973-82.
2
[Laboratory and clinical studies on clarithromycin in pediatrics].
Jpn J Antibiot. 1989 Feb;42(2):264-79.
3
[Bacteriological, pharmacokinetic and clinical studies on clarithromycin in the pediatric field. Pediatric Study Group of Clarithromycin].[克拉霉素在儿科领域的细菌学、药代动力学及临床研究。克拉霉素儿科研究组]
Jpn J Antibiot. 1989 Feb;42(2):512-41.
4
[Basic and clinical studies on clarithromycin in pediatrics].
Jpn J Antibiot. 1989 Feb;42(2):304-22.
5
[Pharmacokinetic, bacteriological and clinical studies in the pediatric field on clarithromycin].[克拉霉素在儿科领域的药代动力学、细菌学及临床研究]
Jpn J Antibiot. 1989 Feb;42(2):281-303.
6
[Basic and clinical studies on use of clarithromycin granules in pediatrics].克拉霉素颗粒在儿科应用的基础与临床研究
Jpn J Antibiot. 1989 Feb;42(2):393-400.
7
[Laboratory and clinical studies on clarithromycin in the field of pediatrics].
Jpn J Antibiot. 1989 Feb;42(2):324-38.
8
[Clinical evaluation of clarithromycin, a new macrolide antibiotic in children].
Jpn J Antibiot. 1989 Feb;42(2):255-62.
9
[Clinical evaluation of clarithromycin in pediatric patients].
Jpn J Antibiot. 1989 Feb;42(2):343-51.
10
[Pharmacokinetics of clarithromycin granule and tablet in children].
Jpn J Antibiot. 1989 Feb;42(2):465-94.

引用本文的文献

1
Systematic Review of Salivary Versus Blood Concentrations of Antituberculosis Drugs and Their Potential for Salivary Therapeutic Drug Monitoring.抗结核药物唾液浓度与血液浓度及其唾液治疗药物监测潜力的系统评价。
Ther Drug Monit. 2018 Feb;40(1):17-37. doi: 10.1097/FTD.0000000000000462.